glp 1 agonist history Discovery of GLP-1–Based Drugs for the Treatment of Obesity It's important to study the

Circ Res 116(9):15091526

Correction: An earlier version of this story incorrectly reported that Dr

Anne Marie Morse explains how these therapies work, first in combating obesity and weight loss, and then she describes how they can be used to combat OSA

Current data suggest that the oral formulation leads to clinically meaningful weight loss, but on average, it appears less effective than higher doses of high-efficacy injectable GLP-1 therapies, says Jaime Almandoz, MD, medical director of UT Southwestern Medical Centers weight wellness program

Biomedicine & pharmacotherapy prevention of pentylenetetrazole-induced kindling and behavioral comorbidities in mice by levetiracetam combined with the GLP-1 agonist liraglutide : involvement of brain antioxidant and BDNF upregulating properties